View All Key Stats
EXEL Key Stats
| Income Statement | |
| Revenue (TTM) | 71.47M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.84 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -189.57M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 95.70% |
| Profit Margin (Quarterly) | -102.1% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 2.957B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 40.54 |
| PE Ratio (TTM) | -- |
| Price to Book Value | -- |
| Other | |
| Beta | Upgrade |
| Debt to Equity Ratio (Quarterly) | -2.128 |
| Free Cash Flow (Quarterly) | -26.28M |
| Return on Equity (TTM) | 133.7% |
View All EXEL News
EXEL News
-
WireHeadlineTime (ET)
-
Yahoo09/29 17:18
-
SA Breaking News09/29 11:00
-
Yahoo09/28 16:48
-
Yahoo09/28 14:21
-
SA Breaking News09/28 12:48
-
Yahoo09/26 16:36
-
MT Newswires09/26 11:22
-
SA Breaking News09/26 10:28
-
Yahoo09/26 10:15
-
Yahoo09/26 08:33
View All Events
EXEL Events
| Date | Type | Description |
|---|---|---|
| 08/03/2016 17:00 EDT | Misc | Exelixis Inc Second Quarter Earnings Conference Call in 2016 |
| 08/03/2016 | Earnings | Exelixis Inc Second Quarter Earnings in 2016 Release |
| 06/06/2016 | Misc | Exelixis Inc Annual General Meeting in 2016 |
| 06/05/2016 | Misc | Exelixis Announces Genentech Presentation of Preliminary Phase 1b Trial Results for the Combination of Cobimetinib and Atezolizumab at Asco 2016 Annual Meeting |
| 05/04/2016 17:00 EDT | Misc | Exelixis Inc First Quarter Earnings Conference Call in 2016 |
| 05/04/2016 | Earnings | Exelixis Inc First Quarter Earnings in 2016 Release |
| 02/29/2016 17:00 EST | Misc | Exelixis Inc Fourth Quarter Earnings Conference Call in 2015 |
| 02/29/2016 | Earnings | Exelixis Inc Fourth Quarter Earnings in 2015 Release |
| 11/10/2015 17:00 EDT | Misc | Exelixis Inc Third Quarter Earnings Conference Call in 2015 |
| 11/10/2015 | Earnings | Exelixis Inc Third Quarter Earnings in 2015 Release |
EXEL Fundamentals
Income Statement View Statement
EXEL Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
One Page Reports
- One Page Report Download
Edit
Profile
- URL: http://www.exelixis.com
- Investor Relations URL: http://www.exelixis.com/investors-media
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: August 03, 2016
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Exelixis Inc is a biotechnology company that develops small molecule therapies for the treatment of cancer.
EXEL Comparables
EditEXEL Excel Add-In Codes
- Name: =YCI("EXEL","name")
- Description: =YCI("EXEL","description")
- Sector: =YCI("EXEL","sector")
- Industry: =YCI("EXEL","industry")
- Est. Current Fiscal Year End: =YCI("EXEL","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other EXEL Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- EXEL Tweets Stocktwits
Advertisement